ALVOAlvotech同业对比
Alvotech 与Biological Products, (No Diagnostic Substances)的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Biological Products, (No Diagnostic Substances))| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALVO本股 | — | — | — | — | — | — | — | — | — | — | — | — |
| ABOS | $185M#4 | — | 2.1x#2 | — | — | -18.6%#7 | — | -138.7%#4 | -185.6%#3 | — | 96.9%#1 | — |
| ABPO | — | — | — | — | 50.0%#3 | 218.1%#1 | -4618.6%#6 | — | — | — | — | — |
| ABPWW | $116152#7 | 0.0x#1 | — | 0.6x#1 | 50.0%#3 | 218.1%#1 | -4618.6%#6 | — | — | — | -60.9%#6 | — |
| ACOG | $188M#3 | — | 3.3x#3 | 18.4x#5 | — | -39.8%#9 | -221.7%#5 | -36.0%#3 | — | — | -21.7%#3 | — |
| ADAPY | — | — | — | — | 195.3%#1 | 37.8%#5 | -38.6%#4 | — | — | — | — | — |
| ADMA | $2.1B#2 | 13.6x#3 | 5.5x#4 | 4.2x#3 | 19.6%#5 | -25.7%#8 | 37.5%#1 | 37.6%#1 | 34.3%#1 | 5#1 | -50.0%#5 | — |
| ADPT | $3.3B#1 | — | 15.4x#5 | 12.1x#4 | 54.8%#2 | 62.7%#4 | -20.6%#3 | -27.5%#2 | -21.2%#2 | — | 72.8%#2 | — |
| AGEN | $133M#5 | 1.6x#2 | — | 1.2x#2 | 10.4%#6 | 98.7%#3 | -17.7%#2 | — | — | — | -46.2%#4 | — |
| AIM | $4M#6 | — | 1.9x#1 | 46.8x#6 | -48.2%#7 | 19.4%#6 | -13254.5%#8 | -656.8%#5 | — | — | -96.8%#7 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议